Blog

Archive for the ‘life extension’ category: Page 509

Dec 30, 2017

Report on Doctor’s Healthiest Diet

Posted by in categories: biotech/medical, life extension

The report shows a surprising diet to be healthy and live longer.


Summary: Comparing the Atkins, Rosedale, Paleo, Mediterranean and DASH Diet plans, researchers report on the healthiest options. [This article first appeared on the LongevityFacts website. Author: Brady Hartman.]

Despite all the advances made with lifespan-extending drugs, a healthy diet remains as one of the best ways to stay healthy and live longer. While many dietary regimens can help us lose weight, few people recognize that some of these are downright unhealthy. However, given the multitude of meal plans – such as the Atkins, Rosedale, Paleo, DASH, Mediterranean and the ‘USDA MyFoodPlate’ – which diet is the best for a slim figure and optimal health?

Continue reading “Report on Doctor’s Healthiest Diet” »

Dec 30, 2017

Scientists Say Air Pollution Will Be Our Top Killer by 2050

Posted by in categories: biotech/medical, life extension, sustainability

Can anyone suggest how we can prevent this from happening to us?


Summary: Air pollution and global warming will ascend to the top cause of death in the next three decades, say researchers from the University of Southern California. The scientists add that the polluted air will lead to a rise in lung disease, heart attacks, and strokes. [This article first appeared on the LongevityFacts.com website. Author: Brady Hartman.]

A pair of expert scientists from the University of Southern California (USC) in Los Angeles says that global warming and air pollution will ascend to the top cause of death due to “ischemic heart disease, stroke, cancer, chronic lower respiratory disease.”

Continue reading “Scientists Say Air Pollution Will Be Our Top Killer by 2050” »

Dec 29, 2017

Bioquark Inc. — Cosmos Connection

Posted by in categories: aging, bioengineering, biological, biotech/medical, complex systems, cryonics, DNA, futurism, genetics, health, life extension

http://www.blogtalkradio.com/aquarianradio/2017/12/29/ira-s-…et-theresa

Dec 27, 2017

We are almost to our final goal!

Posted by in categories: biotech/medical, life extension

With only a few days left of 2017 we are $1,206,000 towards our $1,250,000 Winter Fundraiser goal.

Please help us reach our $1,250,000 goal by donating generously today! Remember, your support is crucial to our continued fight against age-related diseases.

Visit: http://www.sens.org/donate

Continue reading “We are almost to our final goal!” »

Dec 27, 2017

Looking Back at 2017: A Year in Rejuvenation Biotechnology

Posted by in categories: biotech/medical, life extension, lifeboat

The end of the year is approaching, and as we prepare for the celebrations for the new year, what could be better than sitting down with a warm drink and recapping 2017 in the world of rejuvenation biotechnology?

Winter kick-off

Continue reading “Looking Back at 2017: A Year in Rejuvenation Biotechnology” »

Dec 25, 2017

Back to Immortality

Posted by in categories: biotech/medical, life extension

Currently have telomerase which can immortalize human cells in a petri dish. Currently we have stem cells and we can take regular cells even from someone who is 100 years old and we can deprogram the cells back to a pluripotent stem cell state. This is effectively de-aging the cells. There is an effort by some researchers (not Dr West) to achieve partial reprogramming of cells. This would be to use the reprogramming mechanisms to de-age cells while retaining differentiation.

Dr West mentions in the fifth video that he strongly disapproves of current stem cell treatment centers.

Continue reading “Back to Immortality” »

Dec 25, 2017

Breakthroughs for Diabetes Treatments

Posted by in categories: biotech/medical, life extension

Recently pharma firms have released new diabetes treatments, including one in the past week. What’s more, a promising new therapy that attacks the cause of type 2 diabetes at its roots is in the development pipeline.


Summary: Recently pharmaceutical firms have released new diabetes treatments, including one in the past week. Moreover, a promising new therapy that attacks the root cause of type 2 diabetes is in the development pipeline. [This article first appeared on the LongevityFacts.com website. Author: Brady Hartman. ]

The CDC recently shocked the public when they reported that 40% of Americans walking around today would develop type 2 diabetes.

Continue reading “Breakthroughs for Diabetes Treatments” »

Dec 25, 2017

Breakthrough Cures for Respiratory Diseases and COPD in the Pipeline

Posted by in categories: biotech/medical, life extension

In a paradigm shift, scientists are starting to regard respiratory disease as a disease of aging and scientists at the Mayo Clinic reversed symptoms of a lung disease in mice using age-reversing senolytic compounds. In addition to senolytics, researchers are developing other treatments for respiratory conditions such as gene therapy.


Summary: In a paradigm shift, scientists are starting to regard respiratory disease as a disease of aging and scientists at the Mayo Clinic reversed symptoms of a lung disease in mice using age-reversing senolytic compounds. In addition to senolytics, researchers are developing other treatments for respiratory conditions such as gene therapy. [This article first appeared on the website LongevityFacts.com. Author: Brady Hartman.]

All of us – both smokers and non-smokers alike – will lose significant lung capacity as we age. Scientists at the Mayo Clinic have developed a promising treatment that rejuvenates the damaged lungs of mice using anti-aging compounds called senolytics.

Continue reading “Breakthrough Cures for Respiratory Diseases and COPD in the Pipeline” »

Dec 25, 2017

Biotech boss backing gene therapy to solve ageing crisis seeks injection of urgency, but scientists preach patience

Posted by in categories: biotech/medical, life extension

Elizabeth Parrish is a proponent of controversial ideas. Rankled by barriers to trials on potential life-enhancing treatments, she used herself as a guinea pig and says the results have borne fruit – but she has irked the science community in the process.


Experimenting on herself didn’t go down well with scientists, but Elizabeth Parrish is convinced gene therapy can increase the length and quality of our lives, and wants early approval for treatments to stem ‘planet’s biggest killer’.

Read more

Dec 23, 2017

Robotic device improves balance and gait in Parkinson’s disease patients

Posted by in categories: biotech/medical, engineering, life extension, robotics/AI

Some 50,000 people in the U.S. are diagnosed with Parkinson’s disease (PD) every year. The American Institute of Neurology estimates there are one million people affected with this neurodegenerative disorder, with 60 years as average age of onset. Falls and fall-related injuries are a major issue for people with Parkinson’s?up to 70 percent of advanced PD patients fall at least once a year and two-thirds suffer recurring falls. These fall rates are twice as high as those of adults of comparable age, so improving balance in patients with Parkinson’s would provide a major health advantage.

Sunil Agrawal, professor of mechanical engineering and of rehabilitation and regenerative medicine at Columbia Engineering, along with Dario Martelli, a post-doctoral researcher in his group, have been working on this issue with Movement Disorders faculty from the department of neurology at Columbia University Medical Center?Stanley Fahn, a leading expert in Parkinson’s, and Un Jung Kang, division director, and Movement Disorder Fellow Lan Luo. In their latest study, published today in Scientific Reports, the team looked at whether or not Parkinson’s disease affects patients’ balance and diminishes their ability to react and adapt to walking with perturbations. The researchers found that the ability to adapt to multiple perturbations or to modify responses to changing amplitudes or directions was not affected by PD; both the Parkinson’s and the healthy subjects controlled their reactive strategies in the same way.

Read more